CBLB-612

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameCBLB-612
Drug Alias NameCBLB-612H6101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 2 agonistsToll like receptor 6 agonists
TargetsToll like receptor 2Toll like receptor 6
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCleveland Biolabs Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCleveland Biolabs IncZhejiang Hisun Pharmaceutical Co LtdBiolab 612 Llc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A